Sundrug Co.,Ltd.
SDGCF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $801,811 | $751,777 | $690,462 | $648,734 |
| % Growth | 6.7% | 8.9% | 6.4% | – |
| Cost of Goods Sold | $597,723 | $562,457 | $3,903 | $4,044 |
| Gross Profit | $204,087 | $189,320 | $1,294 | $1,286 |
| % Margin | 25.5% | 25.2% | 0.2% | 0.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $10 | $0 | $0 | $0 |
| SG&A Expenses | $142,305 | -$5 | $1,012 | $1,006 |
| Sales & Mktg Exp. | $142,295 | $0 | $0 | $0 |
| Other Operating Expenses | $17,287 | $148,324 | $0 | $0 |
| Operating Expenses | $159,592 | $148,319 | $1,012 | $1,006 |
| Operating Income | $44,496 | $40,996 | $37,452 | $34,052 |
| % Margin | 5.5% | 5.5% | 5.4% | 5.2% |
| Other Income/Exp. Net | -$927 | $265 | $258 | $623 |
| Pre-Tax Income | $43,569 | $41,261 | $37,710 | $34,675 |
| Tax Expense | $12,818 | $12,134 | $12,007 | $10,821 |
| Net Income | $30,750 | $29,126 | $25,703 | $23,853 |
| % Margin | 3.8% | 3.9% | 3.7% | 3.7% |
| EPS | 262.91 | 249.07 | 219.83 | 204.02 |
| % Growth | 5.6% | 13.3% | 7.7% | – |
| EPS Diluted | 262.91 | 249.07 | 219.82 | 204.01 |
| Weighted Avg Shares Out | 117 | 117 | 117 | 117 |
| Weighted Avg Shares Out Dil | 117 | 117 | 117 | 117 |
| Supplemental Information | – | – | – | – |
| Interest Income | $151 | $120 | $119 | $122 |
| Interest Expense | $164 | $32 | $36 | $9 |
| Depreciation & Amortization | $17,282 | $15,127 | $12,068 | $10,209 |
| EBITDA | $61,015 | $56,124 | $49,814 | $44,893 |
| % Margin | 7.6% | 7.5% | 7.2% | 6.9% |